SI-BONE, Inc. (SIBN)
USD 13.71
(-4.53%)
USD 13.71
(-4.53%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -43.33 Million USD | 31.11% |
| 2022 | -62.9 Million USD | -4.62% |
| 2021 | -60.12 Million USD | -23.87% |
| 2020 | -48.54 Million USD | -14.01% |
| 2019 | -42.57 Million USD | -143.95% |
| 2018 | -17.45 Million USD | 24.25% |
| 2017 | -23.03 Million USD | -11.9% |
| 2016 | -20.58 Million USD | 26.87% |
| 2015 | -28.15 Million USD | -1.25% |
| 2014 | -27.8 Million USD | -351.84% |
| 2013 | -6.15 Million USD | 43.56% |
| 2012 | -10.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -10.9 Million USD | 0.72% |
| 2024 Q2 | -8.93 Million USD | 18.02% |
| 2023 Q2 | -11.2 Million USD | -10.74% |
| 2023 Q1 | -10.11 Million USD | 8.48% |
| 2023 Q4 | -10.98 Million USD | -9.59% |
| 2023 FY | -43.33 Million USD | 31.11% |
| 2023 Q3 | -10.02 Million USD | 10.57% |
| 2022 Q2 | -18.51 Million USD | -3.13% |
| 2022 Q3 | -14.75 Million USD | 20.33% |
| 2022 Q4 | -11.05 Million USD | 25.04% |
| 2022 FY | -62.9 Million USD | -4.62% |
| 2022 Q1 | -17.95 Million USD | -24.01% |
| 2021 Q4 | -14.47 Million USD | 8.8% |
| 2021 Q3 | -15.87 Million USD | -13.53% |
| 2021 Q1 | -12.24 Million USD | -36.34% |
| 2021 FY | -60.12 Million USD | -23.87% |
| 2021 Q2 | -13.98 Million USD | -14.21% |
| 2020 Q4 | -8.97 Million USD | 5.22% |
| 2020 Q3 | -9.47 Million USD | 24.04% |
| 2020 FY | -48.54 Million USD | -14.01% |
| 2020 Q1 | -12.77 Million USD | -40.38% |
| 2020 Q2 | -12.47 Million USD | 2.35% |
| 2019 Q4 | -9.09 Million USD | 19.53% |
| 2019 Q3 | -11.3 Million USD | -30.64% |
| 2019 Q2 | -8.65 Million USD | 7.39% |
| 2019 FY | -42.57 Million USD | -143.95% |
| 2019 Q1 | -9.34 Million USD | -75.96% |
| 2018 Q2 | -3.14 Million USD | 25.09% |
| 2018 Q3 | -4.79 Million USD | -52.27% |
| 2018 Q4 | -5.31 Million USD | -10.83% |
| 2018 FY | -17.45 Million USD | 24.25% |
| 2018 Q1 | -4.2 Million USD | 14.35% |
| 2017 Q4 | -4.9 Million USD | 13.69% |
| 2017 Q1 | -6.58 Million USD | 0.0% |
| 2017 FY | -23.03 Million USD | -11.9% |
| 2017 Q2 | -5.86 Million USD | 11.03% |
| 2017 Q3 | -5.68 Million USD | 3.05% |
| 2016 Q1 | -6.64 Million USD | 0.0% |
| 2016 FY | -20.58 Million USD | 26.87% |
| 2015 Q1 | -7.59 Million USD | 11.54% |
| 2015 FY | -28.15 Million USD | -1.25% |
| 2014 Q1 | -3.76 Million USD | 0.0% |
| 2014 FY | -27.8 Million USD | -351.84% |
| 2014 Q4 | -8.58 Million USD | 0.0% |
| 2013 FY | -6.15 Million USD | 43.56% |
| 2012 FY | -10.9 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 46.933% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 29.67% |
| Bioventus Inc. | -156.23 Million USD | 72.261% |
| BrainsWay Ltd. | -4.19 Million USD | -932.547% |
| Cerus Corporation | -37.48 Million USD | -15.597% |
| Envoy Medical, Inc. | -29.9 Million USD | -44.898% |
| electroCore, Inc. | -18.83 Million USD | -130.095% |
| IceCure Medical Ltd | -14.65 Million USD | -195.768% |
| OrthoPediatrics Corp. | -20.97 Million USD | -106.618% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 17.715% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -215.281% |
| MaxCyte, Inc. | -37.92 Million USD | -14.274% |
| Nexalin Technology, Inc. | -4.64 Million USD | -832.216% |
| PAVmed Inc | -64.17 Million USD | 32.472% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -295.571% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 17.403% |
| RxSight, Inc. | -48.6 Million USD | 10.846% |
| Sight Sciences, Inc. | -55.54 Million USD | 21.983% |
| TELA Bio, Inc. | -46.66 Million USD | 7.132% |
| Talis Biomedical Corporation | -62 Million USD | 30.111% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 26.596% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 12.5% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -219.046% |
| Inogen, Inc. | -102.44 Million USD | 57.7% |
| Spectral AI, Inc. | -20.85 Million USD | -107.807% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 28.696% |
| CVRx, Inc. | -41.19 Million USD | -5.187% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 6869.177% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -389.672% |
| Orthofix Medical Inc. | -151.39 Million USD | 71.376% |
| Venus Concept Inc. | -37.25 Million USD | -16.338% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -265.412% |
| LivaNova PLC | 17.54 Million USD | 346.985% |
| 908 Devices Inc. | -36.39 Million USD | -19.058% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 76.781% |
| Nemaura Medical Inc. | -14.14 Million USD | -206.397% |
| NeuroPace, Inc. | -32.95 Million USD | -31.497% |
| LENSAR, Inc. | -14.38 Million USD | -201.3% |
| Apyx Medical Corporation | -18.71 Million USD | -131.582% |
| Cutera, Inc. | -162.83 Million USD | 73.386% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -300.148% |
| BioSig Technologies, Inc. | -29.04 Million USD | -49.224% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 47.578% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -96.188% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 163.973% |
| Axonics, Inc. | -6.08 Million USD | -611.827% |
| Outset Medical, Inc. | -172.79 Million USD | 74.921% |
| IRIDEX Corporation | -9.57 Million USD | -352.832% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 59.077% |
| IRadimed Corporation | 17.19 Million USD | 352.059% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -425.667% |
| INVO Bioscience, Inc. | -8.03 Million USD | -439.366% |
| Telesis Bio, Inc. | -47.72 Million USD | 9.195% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 523.079% |
| Varex Imaging Corporation | -47.7 Million USD | 9.149% |
| Quipt Home Medical Corp. | -2.78 Million USD | -1456.609% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -283.98% |
| Pulmonx Corporation | -60.84 Million USD | 28.774% |
| Dynatronics Corporation | -2.69 Million USD | -1506.394% |
| Modular Medical, Inc. | -17.47 Million USD | -148.06% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -280.574% |
| Semler Scientific, Inc. | 20.58 Million USD | 310.543% |
| InMode Ltd. | 197.91 Million USD | 121.896% |
| Bruker Corporation | 427.2 Million USD | 110.144% |
| Cytosorbents Corporation | -28.5 Million USD | -52.017% |
| DexCom, Inc. | 541.5 Million USD | 108.003% |
| Align Technology, Inc. | 445.05 Million USD | 109.737% |
| Viveve Medical, Inc. | -22.02 Million USD | -96.74% |
| ZimVie Inc. | -393.28 Million USD | 88.981% |
| Movano Inc. | -29.28 Million USD | -47.99% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -256.734% |
| Nexalin Technology, Inc. | -4.64 Million USD | -832.216% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 6869.177% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 80.533% |
| Profound Medical Corp. | -28.56 Million USD | -51.689% |
| Insulet Corporation | 206.3 Million USD | 121.006% |
| enVVeno Medical Corporation | -23.51 Million USD | -84.283% |
| Surmodics, Inc. | -11.54 Million USD | -275.464% |
| iCAD, Inc. | -4.84 Million USD | -794.079% |
| Nuwellis, Inc. | -20.2 Million USD | -114.439% |
| Biotricity, Inc. | -14.09 Million USD | -207.472% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 64.883% |
| Aethlon Medical, Inc. | -12.2 Million USD | -254.975% |
| InspireMD, Inc. | -19.91 Million USD | -117.594% |
| PAVmed Inc. | -64.17 Million USD | 32.472% |
| BIOLASE, Inc. | -20.63 Million USD | -110.043% |
| Beyond Air, Inc. | -60.24 Million USD | 28.063% |
| FONAR Corporation | 10.56 Million USD | 510.092% |
| AxoGen, Inc. | -21.71 Million USD | -99.558% |
| Vivani Medical, Inc. | -25.65 Million USD | -68.938% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 251.976% |
| Inari Medical, Inc. | -1.63 Million USD | -2548.9% |
| UFP Technologies, Inc. | 44.92 Million USD | 196.465% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -744.372% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -556.088% |
| Tenon Medical, Inc. | -15.58 Million USD | -178.134% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -180.928% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -22.651% |
| AdaptHealth Corp. | -678.89 Million USD | 93.617% |
| Sintx Technologies, Inc. | -8.25 Million USD | -424.712% |
| NanoVibronix, Inc. | -3.71 Million USD | -1067.771% |
| Quanterix Corporation | -32.33 Million USD | -34.026% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -283.98% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 9035.258% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 85.872% |
| TransMedics Group, Inc. | -25.02 Million USD | -73.15% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -95.798% |
| NeuroMetrix, Inc. | -6.52 Million USD | -563.697% |
| Hyperfine, Inc. | -44.23 Million USD | 2.039% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 44.796% |
| Biomerica, Inc. | -5.97 Million USD | -624.925% |
| Bone Biologics Corporation | -8.94 Million USD | -384.27% |
| AVITA Medical, Inc. | -39.16 Million USD | -10.641% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -335.368% |
| Silk Road Medical, Inc | -55.74 Million USD | 22.258% |